Segui
Davide Cangelosi
Davide Cangelosi
Senior Investigator, IRCCS Giannina Gaslini Institute
Email verificata su gaslini.org
Titolo
Citata da
Citata da
Anno
The P2X7 receptor is a key modulator of the PI3K/GSK3β/VEGF signaling network: evidence in experimental neuroblastoma
F Amoroso, M Capece, A Rotondo, D Cangelosi, M Ferracin, ...
Oncogene 34 (41), 5240-5251, 2015
1742015
Hypoxia modifies the transcriptome of human NK cells, modulates their immunoregulatory profile, and influences NK cell subset migration
M Parodi, F Raggi, D Cangelosi, C Manzini, M Balsamo, F Blengio, A Eva, ...
Frontiers in immunology 9, 418208, 2018
1192018
Exosomal microRNAs from longitudinal liquid biopsies for the prediction of response to induction chemotherapy in high-risk neuroblastoma patients: a proof of concept SIOPEN study‖
M Morini, D Cangelosi, D Segalerba, D Marimpietri, F Raggi, A Castellano, ...
Cancers 11 (10), 1476, 2019
502019
Hypoxia predicts poor prognosis in neuroblastoma patients and associates with biological mechanisms involved in telomerase activation and tumor microenvironment reprogramming
D Cangelosi, M Morini, N Zanardi, AR Sementa, M Muselli, M Conte, ...
Cancers 12 (9), 2343, 2020
422020
Optimized parallel implementation of gillespie's first reaction method on graphics processing units
C Dittamo, D Cangelosi
2009 International Conference on Computer Modeling and Simulation, 156-161, 2009
382009
Artificial neural network classifier predicts neuroblastoma patients’ outcome
D Cangelosi, S Pelassa, M Morini, M Conte, MC Bosco, A Eva, ...
Bmc Bioinformatics 17, 83-93, 2016
372016
Logic Learning Machine creates explicit and stable rules stratifying neuroblastoma patients
D Cangelosi, F Blengio, R Versteeg, A Eggert, A Garaventa, C Gambini, ...
BMC bioinformatics 14, 1-20, 2013
332013
Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants
A Dondero, M Morini, D Cangelosi, K Mazzocco, M Serra, GM Spaggiari, ...
Journal for Immunotherapy of Cancer 9 (4), 2021
292021
CHL1 gene acts as a tumor suppressor in human neuroblastoma
M Ognibene, G Pagnan, D Marimpietri, D Cangelosi, M Cilli, ...
Oncotarget 9 (40), 25903, 2018
272018
Secondary somatic mutations in G-protein-related pathways and mutation signatures in uveal melanoma
F Piaggio, V Tozzo, C Bernardi, M Croce, R Puzone, S Viaggi, S Patrone, ...
Cancers 11 (11), 1688, 2019
262019
Spontaneous NLRP3 inflammasome-driven IL-1-β secretion is induced in severe COVID-19 patients and responds to anakinra treatment
A Bertoni, F Penco, H Mollica, P Bocca, I Prigione, A Corcione, ...
Journal of Allergy and Clinical Immunology 150 (4), 796-805, 2022
252022
Use of Attribute Driven Incremental Discretization and Logic Learning Machine to build a prognostic classifier for neuroblastoma patients
D Cangelosi, M Muselli, S Parodi, F Blengio, P Becherini, R Versteeg, ...
BMC bioinformatics 15, 1-15, 2014
252014
The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma
S Grasso, D Cangelosi, J Chapelle, M Alzona, G Centonze, A Lamolinara, ...
Cell Death & Differentiation 27 (2), 790-807, 2020
22*2020
Immunohistochemical analysis of PDK1, PHD3 and HIF-1α expression defines the hypoxic status of neuroblastoma tumors
M Ognibene, D Cangelosi, M Morini, D Segalerba, MC Bosco, ...
PLoS One 12 (11), e0187206, 2017
192017
Circulating microRNAs as novel non-invasive biomarkers of paediatric celiac disease and adherence to gluten-free diet
C Felli, A Baldassarre, P Uva, A Alisi, D Cangelosi, M Ancinelli, M Caruso, ...
EBioMedicine 76, 2022
152022
Transcriptome analysis defines myocardium gene signatures in children with ToF and ASD and reveals disease-specific molecular reprogramming in response to surgery with …
F Raggi, D Cangelosi, P Becherini, F Blengio, M Morini, M Acquaviva, ...
Journal of Translational Medicine 18, 1-20, 2020
132020
PIPE-T: a new Galaxy tool for the analysis of RT-qPCR expression data
N Zanardi, M Morini, MA Tangaro, F Zambelli, MC Bosco, L Varesio, ...
Scientific Reports 9 (1), 17550, 2019
132019
Circulating exosomal microRNAs as potential biomarkers of hepatic injury and inflammation in a murine model of glycogen storage disease type 1a
R Resaz, D Cangelosi, M Morini, D Segalerba, L Mastracci, F Grillo, ...
Disease Models & Mechanisms 13 (9), dmm043364, 2020
112020
Favorable prognostic role of tropomodulins in neuroblastoma
P Bettinsoli, G Ferrari-Toninelli, SA Bonini, M Guarienti, D Cangelosi, ...
Oncotarget 9 (43), 27092, 2018
112018
Connectivity map analysis indicates PI3K/Akt/mTOR inhibitors as potential anti-hypoxia drugs in neuroblastoma
P Uva, MC Bosco, A Eva, M Conte, A Garaventa, L Amoroso, D Cangelosi
Cancers 13 (11), 2809, 2021
102021
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20